Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Foundayo (orforglipron) adds flexibility as a new oral GLP-1 alternative not bound by mealtime constraints
When to contact your pharmacy Contact your pharmacy if you observe any of the following: an unexpected color change, cloudiness that was not present when you first opened the product, particles or debris in the solution, a damaged pen or vial, a product that appears to have been tampered with or previously opened, or any discrepancy between the product appearance and what you have received previously
Written By: Abhinay Wadekar, Shreya Bendsure and Sheetal Barbade, BPharm Medically Reviewed By: Dr
Patient experiences can vary widely, influenced by individual tolerance and health goals
Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Biocon Limited, Boehringer Ingelheim International GmbH, Amgen Inc., AstraZeneca PLC, Roche Holding AG, Zealand Pharma A/S, Hanmi Pharmaceutical Co., Ltd., Structure Therapeutics Inc., Altimmune, Inc., United Laboratories International Holdings Limited, Entera Bio Ltd., OPKO Health, Inc., Viking Therapeutics, Inc., Twist Bioscience Corporation and others GLP-1 agonists market is segmented based on Product, Indication , Route of Administration, Distribution Channel and Region
US$ 23.54
US$ 25.17
US$ 28.35
US$ 25.94
US$ 24.92
US$ 21.74
US$ 21.29
